Akiyama Yuto, Horiuchi Kohei, Kondo Yasushi, Kabata Hiroki, Ishii Makoto, Fukunaga Koichi
Division of Pulmonary Medicine, Department of Medicine Keio University School of Medicine Shinjuku Tokyo Japan.
Division of Rheumatology, Department of Medicine Keio University School of Medicine Shinjuku Tokyo Japan.
Respirol Case Rep. 2020 Jul 15;8(7):e00622. doi: 10.1002/rcr2.622. eCollection 2020 Oct.
Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 is rapidly spreading worldwide. A typical clinical manifestation of COVID-19 is pneumonia, which can progress to acute respiratory distress syndrome and respiratory failure. Recent studies have reported that COVID-19 is often accompanied by coagulopathy, and a significant number of patients with severe or critical COVID-19 develop concomitant thrombosis, including pulmonary embolism (PE). However, there are limited reports of the incidence of PE in non-severe COVID-19 patients. Here, we report a case of non-severe COVID-19 complicated by PE, which indicates that the possibility of PE should consistently be considered, even in non-severe cases of COVID-19 without any risk of thrombosis.
由严重急性呼吸综合征冠状病毒 2 引起的 2019 新型冠状病毒病（COVID-19）正在全球迅速传播。COVID-19 的典型临床表现为肺炎，可进展为急性呼吸窘迫综合征和呼吸衰竭。最近的研究报告称，COVID-19 常伴有凝血病，大量重症或危重症 COVID-19 患者会并发血栓形成，包括肺栓塞（PE）。然而，关于非重症 COVID-19 患者中 PE 发病率的报道有限。在此，我们报告一例非重症 COVID-19 合并 PE 的病例，这表明即使在没有任何血栓形成风险的非重症 COVID-19 病例中，也应始终考虑 PE 的可能性。
